Viewing Study NCT00299195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-05 @ 1:50 AM
Study NCT ID: NCT00299195
Status: COMPLETED
Last Update Posted: 2020-11-19
First Post: 2006-03-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Randomized Study of Sulindac in Oral Premalignant Lesions
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukoplakia, Oral View
None Benign Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oral Leukoplakia View
None Benign Neoplasms View
None Chemoprevention View
None Pan-cyclooxygenase (COX) inhibitor View
None sulindac View
None 04-099 View